The role of cytokeratin 19 in the differential diagnosis of true papillary carcinoma of thyroid and papillary carcinoma-like changes in Graves’ disease

Author： Erkiliç Suna   Koçer N.  

Publisher： Humana Press, Inc

ISSN： 1046-3976

Source： Endocrine Pathology, Vol.16, Iss.1, 2005-03, pp. : 63-66

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-1

By Casey Mary   Lohse Christine   Lloyd Ricardo  

Endocrine Pathology, Vol. 14, Iss. 1, 2003-03 ,pp. : 55-60

Humana Press, Inc

Access to resources Recommend Favorite

Diagnostic Utility of Cytokeratin 19 Expression in Multinodular Goiter with Papillary Areas and Papillary Carcinoma of Thyroid

By Erkilic Suna   Aydin Abdullah   Kocer Emrah  

Endocrine Pathology, Vol. 13, Iss. 3, 2002-09 ,pp. : 207-211

Humana Press, Inc

Access to resources Recommend Favorite

Sonographic Diagnosis of Papillary Thyroid Carcinoma

By  

Medical Principles and Practice, Vol. 9, Iss. 1, 2000-05 ,pp. : 25-34

Karger

Access to resources Recommend Favorite

Simultaneous diffuse sclerosis variant of papillary thyroid carcinoma and diffuse toxic hyperplasia (Graves’ disease)

By Paner Gladell   Hunt Jennifer   Ciesla Marlyn   DeJong Steven   LiVolsi Virginia  

Endocrine Pathology, Vol. 15, Iss. 1, 2004-03 ,pp. : 77-82

Humana Press, Inc

Access to resources Recommend Favorite

Warthin tumor-like variant of papillary thyroid carcinoma: A case with dedifferentiation (anaplastic changes) and aggressive biological behavior

By Lam King   Lo Chung   Wei William  

Endocrine Pathology, Vol. 16, Iss. 1, 2005-03 ,pp. : 83-89

Humana Press, Inc

Access to resources Recommend Favorite